Kistler-Tiffany Companies’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
$29K Hold
3,857
﹤0.01% 566
2023
Q1
$34.1K Hold
3,857
0.01% 474
2022
Q4
$35.2K Sell
3,857
-126
-3% -$1.15K 0.01% 459
2022
Q3
$32K Sell
3,983
-156
-4% -$1.25K 0.01% 436
2022
Q2
$31K Hold
4,139
0.01% 440
2022
Q1
$39K Hold
4,139
0.01% 423
2021
Q4
$33K Buy
4,139
+3,738
+932% +$29.8K 0.01% 424
2021
Q3
$4K Buy
401
+126
+46% +$1.26K ﹤0.01% 650
2021
Q2
$3K Hold
275
﹤0.01% 643
2021
Q1
$3K Hold
275
﹤0.01% 598
2020
Q4
$3K Hold
275
﹤0.01% 580
2020
Q3
$2K Hold
275
﹤0.01% 594
2020
Q2
$3K Sell
275
-300
-52% -$3.27K ﹤0.01% 544
2020
Q1
$6K Hold
575
﹤0.01% 490
2019
Q4
$6K Hold
575
﹤0.01% 498
2019
Q3
$4K Sell
575
-875
-60% -$6.09K ﹤0.01% 534
2019
Q2
$13K Hold
1,450
﹤0.01% 414
2019
Q1
$23K Hold
1,450
0.01% 331
2018
Q4
$22K Hold
1,450
0.01% 313
2018
Q3
$31K Hold
1,450
0.01% 295
2018
Q2
$35K Hold
1,450
0.02% 287
2018
Q1
$25K Hold
1,450
0.01% 344
2017
Q4
$27K Sell
1,450
-2,524
-64% -$47K 0.01% 340
2017
Q3
$70K Buy
3,974
+301
+8% +$5.3K 0.03% 236
2017
Q2
$122K Buy
3,673
+1,571
+75% +$52.2K 0.06% 174
2017
Q1
$67K Sell
2,102
-188
-8% -$5.99K 0.03% 224
2016
Q4
$83K Sell
2,290
-147
-6% -$5.33K 0.04% 206
2016
Q3
$112K Buy
2,437
+302
+14% +$13.9K 0.06% 177
2016
Q2
$107K Buy
2,135
+64
+3% +$3.21K 0.05% 178
2016
Q1
$111K Buy
2,071
+2
+0.1% +$107 0.06% 167
2015
Q4
$175K Sell
2,069
-298
-13% -$25.2K 0.1% 132
2015
Q3
$134K Buy
2,367
+1
+0% +$57 0.08% 159
2015
Q2
$140K Buy
2,366
+2
+0.1% +$118 0.08% 156
2015
Q1
$147K Buy
2,364
+1
+0% +$62 0.09% 134
2014
Q4
$136K Buy
2,363
+1
+0% +$58 0.09% 138
2014
Q3
$127K Hold
2,362
0.08% 151
2014
Q2
$124K Buy
2,362
+100
+4% +$5.25K 0.09% 148
2014
Q1
$120K Hold
2,262
0.09% 142
2013
Q4
$91K Sell
2,262
-184
-8% -$7.4K 0.07% 173
2013
Q3
$92K Hold
2,446
0.07% 165
2013
Q2
$96K Buy
+2,446
New +$96K 0.08% 151